vildagliptin stada 50 mg
stada arzneimittel ag, nemecko - vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
azacitidín ever pharma 25 mg/ml prášok na injekčnú suspenziu
ever valinject gmbh, rakúsko - azacitidín - 44 - cytostatica
anvildis 50 mg
vipharm s.a., poľsko - vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin stada 50 mg/1000 mg filmom obalené tablety
stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin stada 50 mg/850 mg filmom obalené tablety
stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
rybrevant
janssen-cilag international n.v. - amivantamab - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
wegovy
novo nordisk a/s - semaglutide - obesity; overweight - prípravky proti obezite, okrem diétne výrobky - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetes mellitus, typ 2 - lieky používané pri cukrovke - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 a 5.
ipinzan 50 mg/1000 mg
zentiva, k.s., Česká republika - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)